Unleashing AI’s Untapped Power in Drug Discovery: The Rise and Challenges of Recursion Pharmaceuticals
Recursion Pharmaceuticals merges artificial intelligence with drug discovery, exemplifying innovation in biotechnology. The company accelerates therapeutic development through AI and high-dimensional data analytics. Backed by a $50 million investment from Nvidia, Recursion continues to draw attention for its data prowess. The AI-driven